Diabetes is pandemic – according to the World Diabetes Organization, more than 285 million people world-wide have diabetes today and the number is expected to double by the year of 2025¹. Many people with type 2 diabetes are unaware of their condition and could benefit from early detection and treatment. Primary care physicians and diabetes specialists play an important role in prevention, early detection and monitoring of diabetes and its complications.

Glucose testing is important in identifying the rapidly increasing number of people with diabetes at an early stage, and to monitor diabetes therapy. Severe complications such as renal and cardiovascular disease can be identified early by the recommended screening for microalbuminuria. Although anemia often accompanies diabetes and is a key indicator of renal disease, most patients with diabetes are rarely tested for it.

Three vital tests for screening, diagnosing or monitoring of diabetes, microalbuminuria and anemia are available from HemoCue^®. Glucose, urine albumin and hemoglobin testing can be done quickly, easily and accurately in primary care settings using the HemoCue^® systems.